Estimation of the causal effects on survival of two-stage nonrandomized treatment sequences for recurrent diseases

Biometrics

Volumn 62, Issue 3, 2006, Pages 901-909

  Huang, Xuelin ^a   Cormier, Janice N ^a   Pisters, Peter W T ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Causal inference; Counterfactual response; Estimating equation; Inverse probability of censoring weighted (IPCW) method; Recurrent event; Survival analysis

Indexed keywords

DIAGNOSIS; DISTRIBUTION FUNCTIONS; INVERSE PROBLEMS; PATIENT TREATMENT; SALVAGING;

CAUSAL INFERENCES; COUNTERFACTUAL RESPONSE; COUNTERFACTUALS; ESTIMATING EQUATIONS; INITIAL TREATMENT; INVERSE PROBABILITY OF CENSORING WEIGHTED METHOD; RECURRENT EVENTS; SALVAGE TREATMENT; SURVIVAL ANALYSIS; WEIGHTED METHOD;

DISEASES;

ANTINEOPLASTIC AGENT;

CANCER; DISEASE TREATMENT; ESTIMATION METHOD; SALVAGING; SIMULATION; SURVIVAL;

ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURVIVAL; CANCER THERAPY; CAUSAL MODELING; EVALUATION; FOLLOW UP; RANDOMIZATION; RECURRENT CANCER; RETROSPECTIVE STUDY; SALVAGE THERAPY; SENSITIVITY ANALYSIS; SIMULATION; SOFT TISSUE SARCOMA; STATISTICAL DISTRIBUTION; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 33748785715     PISSN: 0006341X     EISSN: 15410420     Source Type: Journal    
DOI: 10.1111/j.1541-0420.2005.00520.x     Document Type: Article

References (22)

1. American Joint Committee on Cancer. (2002). Cancer Staging Manual, 6th edition. New York: Springer.
2. Coindre, J. M., Terrier, P., Bui, N. B., et al. (1996). Prognostic factors in adult patients with locally controlled soft tissue sarcoma: A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. Journal of Clinical Oncology 14, 869-877.
3. Cormier, J. N., Huang, X., Xing, Y., Thall, P. F., Wang, X., Benjamin, R. S., Pollock, R. E., Antonescu, C. R., Maki, R. G., Brennan, M. F., and Pisters, P. W. T. (2004). Cohort analysis of 674 patients with localized high-risk extremity soft tissue sarcoma treated at two cancer centers: Chemotherapy-associated outcomes. Journal of Clinical Oncology 22, 4567-4574.
4. Cox, D. R. (1972). Regression models and life tables (with discussion). Journal of the Royal Statistical Society, Series B 34, 187-220.
5. Hastie, T. J. and Tibshirani, R. J. (1990). Generalized Additive Models. London and New York: Chapman & Hall/CRC.
6. Holland, P. W. (1986). Statistics and causal inference. Journal of the American Statistical Association 81, 945-960.
7. Kaplan, E. L. and Meier, P. (1958). Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 53, 457-481.
8. Liu, L., Wolfe, R. A., and Huang, X. (2004). Shared frailty models for recurrent events and a terminal event. Biometrics 60, 747-756.
9. Lunceford, J. K., Davidian, M., and Tsiatis, A. A. (2002). Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials. Biometrics 58, 48-57.
10. Murphy, S. A. (2003). Optimal dynamic treatment regimens (with discussion). Journal of the Royal Statistical Society, Series B 65, 331-366.
11. Murphy, S. A., van der Laan, M. J., Robins, J. M., and Conduction Problems Prevention Research Group. (2001). Marginal mean models for dynamic regimens. Journal of the American Statistical Association 96, 1410-1423.
12. Pisters, P. W., Leung, D. H., Woodruff, J., Shi, W., and Brennan, M. F. (1996). Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. Journal of Clinical Oncology 14, 1679-1689.
13. Robins, J. M. (1997). Causal inference from complex longitudinal data. In Latent Variable Modeling and Applications to Causality, M. Berkane (ed), 69-117. New York: Springer-Verlag.
14. Robins, J. M. and Finkelstein, D. M. (2000). Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted log-rank tests. Biometrics 56, 779-788.
15. Robins, J. M. and Greenland, S. (1994). Adjusting for differential rates of prophylaxis therapy for PCP in high- versus low-dose AZT treatment arms in an AIDS randomized trial. Journal of the American Statistical Association 89, 737-749.
16. Robins, J. M. and Rotnitzky, A. (1992). Recovery of information and adjustment for dependent censoring using surrogate markers. In AIDS Epidemiology: Methodological Issues, N. P. Jewell, K. Dietz, and V. T. Farewell (eds), 297-331. Boston: Birkhöuser.
17. Rubin, D. B. (1986). Comments on the paper by Dr. P. W. Holland, " Statistics and causal inference." Journal of the American Statistical Association 81, 961-962.
18. Strawderman, R. L. (2000). Estimating the mean of an increasing stochastic process at a censored stopping time. Journal of the American Statistical Association 95, 1192-1208.
19. Tierney, J. F. (1997). Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: Meta-analysis of individual data. Sarcoma Meta-Analysis Collaboration. Lancet 350, 1647-1654.
20. Wahed, A. S. and Tsiatis, A. A. (2004). Optimal estimator for the survival distribution and related quantities for treatment policies in two-stage randomization designs in clinical trials. Biometrics 60, 124-133.
21. Zagars, G. K., Ballo, M. T., Pisters, P. W., Pollock, R. E., Patel, S. R., Benjamin, R. S., and Evans, H. L. (2003). Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: An analysis of 225 patients. Cancer 97, 2530-2543.
22. Zhao, H. and Tsiatis, A. A. (1997). A consistent estimator for the distribution of quality-adjusted survival time. Biometrika 84, 339-348.